SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Cannabis > Therapix Biosciences Ltd. ADR (THXBY)

Therapix Biosciences ADRs Begin Trading on the OTCQB(R)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ash111 Member Profile
Member Level 
Followed By 1,099
Posts 188,298
Boards Moderated 9
Alias Born 06/19/09
160x600 placeholder
Therapix Biosciences Announces Completion of Enrollment of Phase IIa Study at Yale University for Tourette Syndrome Program "PR Newswire (US)" - 12/4/2017 8:30:00 AM
Therapix Biosciences Spotlighted in Financial and Trade Media Outlets "PR Newswire (US)" - 11/21/2017 8:30:00 AM
Therapix Biosciences Plans Preclinical Study to Evaluate Opioid-Sparing Effects of Two Innovative Synthetic Cannabinoids "PR Newswire (US)" - 11/10/2017 8:30:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/9/2017 8:13:08 AM
Therapix Biosciences Reports Third Quarter 2017 Financial Results and Provides Business Update "PR Newswire (US)" - 11/9/2017 8:00:00 AM
Cure Pharmaceutical Enters Into Product Development Agreement with Therapix Biosciences To Develop Cannabinoid-Based Product ... "GlobeNewswire Inc." - 11/7/2017 9:00:00 AM
Therapix to Present at and Attend Investor Conferences in London "PR Newswire (US)" - 11/7/2017 8:30:00 AM
Therapix Biosciences Third Quarter 2017 Conference Call and Webcast Scheduled for Thursday, November 9, 2017 "PR Newswire (US)" - 11/2/2017 2:30:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/2/2017 8:31:56 AM
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer "PR Newswire (US)" - 11/2/2017 8:30:00 AM
Therapix Biosciences Initiates Non-clinical Studies for its Antibacterial Program in Collaboration With the Weizmann Institut... "PR Newswire (US)" - 10/30/2017 8:30:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/25/2017 10:52:21 AM
Therapix Biosciences and Assuta Medical Center to Initiate Clinical Trial in Obstructive Sleep Apnea "PR Newswire (US)" - 10/18/2017 8:30:00 AM
Therapix Signs Formulation Development and Clinical Manufacturing Agreement with Catalent for THX-TS01 "PR Newswire (US)" - 10/6/2017 8:30:00 AM
Therapix's First-in-Class Therapy Demonstrates Reversal of Age-Related Cognitive Impairment in Pre-Clinical Study "PR Newswire (US)" - 9/27/2017 8:30:00 AM
Therapix Biosciences Reports Second Quarter 2017 Financial Results and Provides Business Update "PR Newswire (US)" - 8/10/2017 8:00:00 AM
Therapix Biosciences Second Quarter 2017 Conference Call and Webcast Scheduled for Thursday, August 10, 2017 "PR Newswire (US)" - 8/3/2017 8:30:00 AM
CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel’s Assuta Medical Centers to Develop First-in-Class Therape... "GlobeNewswire Inc." - 7/11/2017 9:00:00 AM
CURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel's Assuta Medical Center to Develop First-in-Class Therapeuti... "PR Newswire (US)" - 7/11/2017 8:00:00 AM
Therapix Biosciences to Ring the Nasdaq Stock Market Opening Bell on June 28 "PR Newswire (US)" - 6/27/2017 4:15:00 PM
Therapix Biosciences Ltd. (Nasdaq: TRPX) to Ring The Nasdaq Stock Market Opening Bell "GlobeNewswire Inc." - 6/27/2017 10:00:00 AM
Therapix Biosciences to Present at Upcoming Scientific and Investor Conferences in June "PR Newswire (US)" - 5/30/2017 8:24:00 AM
Therapix Biosciences Announces CEO Change "PR Newswire (US)" - 5/24/2017 5:40:00 PM
Therapix Biosciences and the Hannover Medical School Enter into an Investigator-initiated Clinical Trial Agreement to Assess ... "PR Newswire (US)" - 5/8/2017 8:30:00 AM
Therapix Biosciences Announces the Appointment of Josh Blacher as Chief Financial Officer "PR Newswire (US)" - 5/3/2017 8:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist